These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33796885)

  • 1. Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma.
    Ali NA; Hamdy NM; Gibriel AA; El Mesallamy HO
    Arch Virol; 2021 Jun; 166(6):1643-1651. PubMed ID: 33796885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the interactions of STAT4 rs7574865 with HBV mutations on the risk of hepatocellular carcinoma.
    Yang C; Chen H; Zhou B; Yin J; Cao G; Hou J; Jiang D
    Mol Carcinog; 2022 Oct; 61(10):933-940. PubMed ID: 35880842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
    Chanthra N; Payungporn S; Chuaypen N; Piratanantatavorn K; Pinjaroen N; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(18):8405-10. PubMed ID: 26745093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population.
    Bayram S
    Gene; 2012 May; 498(2):264-9. PubMed ID: 22394463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in STAT4 and their interactions with environmental factors for the incidence of hepatocellular carcinoma.
    Zhong X; Luo M; Wu Y; Zhou X; Yu X; Liu L; Chen S
    Cancer Biomark; 2021; 32(1):3-9. PubMed ID: 33896832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of
    Shi H; He H; Ojha SC; Sun C; Fu J; Yan M; Deng C; Sheng Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160486
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
    El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
    Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of tumour suppressor genes
    El-Bendary M; Nour D; Arafa M; Neamatallah M
    Br J Biomed Sci; 2020 Jan; 77(1):35-40. PubMed ID: 31790342
    [No Abstract]   [Full Text] [Related]  

  • 10. A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma.
    Clark A; Gerlach F; Tong Hv; Hoan NX; Song le H; Toan NL; Bock CT; Kremsner PG; Velavan TP
    Infect Genet Evol; 2013 Aug; 18():257-61. PubMed ID: 23748017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
    Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
    Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis.
    Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
    Pathol Res Pract; 2020 Oct; 216(10):153099. PubMed ID: 32853942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
    Hetta HF; Zahran AM; Mansor SG; Abdel-Malek MO; Mekky MA; Abbas WA
    J Med Virol; 2019 Jul; 91(7):1319-1328. PubMed ID: 30761547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of XRCC1 p. Arg194Trp gene polymorphism with the risk of hepatocellular carcinoma in HCV Egyptian population: A pilot case-control study.
    Ghorab RA; Fouad SH; Elsaadawy Y; Hamdy M; Taha SI
    Int J Immunopathol Pharmacol; 2024; 38():3946320241265263. PubMed ID: 38898405
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population.
    Kim LH; Cheong HS; Namgoong S; Kim JO; Kim JH; Park BL; Cho SW; Park NH; Cheong JY; Koh I; Shin HD; Kim YJ
    Infect Genet Evol; 2015 Jul; 33():72-6. PubMed ID: 25913043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.
    Labib HA; Ahmed HS; Shalaby SM; Wahab EA; Hamed EF
    Cell Immunol; 2015 Mar; 294(1):21-4. PubMed ID: 25666505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat4 rs7574865 polymorphism promotes the occurrence and progression of hepatocellular carcinoma via the Stat4/CYP2E1/FGL2 pathway.
    Wang C; Gao N; Yang L; Guo Y; Fang Y; Wang T; Xu C; Li GF; Zhou J; Zhang Y; Wen Q; Qiao H
    Cell Death Dis; 2022 Feb; 13(2):130. PubMed ID: 35136014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.